<DOC>
	<DOC>NCT00772967</DOC>
	<brief_summary>This study will evaluate a walking model of osteoarthritis for use in testing of new therapeutic agents. The primary hypothesis is that participants treated with Naproxen or Ultracet will have lower Pain Intensity (PI) than those treated with Placebo during self-paced walks on Day 3 of treatment.</brief_summary>
	<brief_title>A Study to Evaluate the Effect of Analgesics on a Walking Model of Knee Pain (0000-105)(COMPLETED)</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Naproxen</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<criteria>Has osteoarthritis of the knee and primary source of pain is knee Females must not be pregnant or nursing and must agree to use birth control throughout the study Is willing to limit alcohol and caffeine intake Is willing to abstain from smoking during study visits Must be able to walk on a treadmill at a pace of at least 1 mile/hour Has a medical/arthritic disease that would interfere with evaluation Is unable to take naproxen or Ultracet Has congestive heart failure or angina Has a history of stroke Has a history of uncontrolled high blood pressure Has a history of cancer Regularly uses a walker or cane</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>